William Hrushesky to Angiogenesis Inhibitors
This is a "connection" page, showing publications William Hrushesky has written about Angiogenesis Inhibitors.
Connection Strength
0.195
-
Adding Bevacizumab to the Treatment of Patients With Non-Small-Cell Lung Cancer: Caveat Emptor. J Oncol Pract. 2015 Sep; 11(5):363-4.
Score: 0.119
-
Hypothesis: primary antiangiogenic method proposed to treat early stage breast cancer. BMC Cancer. 2009 Jan 08; 9:7.
Score: 0.076